![Alexey A. Lugovskoy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Alexey A. Lugovskoy
Chief Executive Officer at
Diagonal Therapeutics, Inc.
Profile
Alexey A. Lugovskoy is the founder of Diagonal Therapeutics, Inc., founded in 2022, where the title held is President & Chief Executive Officer.
The current job is Advisory Board Member at RusBioVentures LLC since 2013.
Former jobs include Associate Director-Drug Discovery at Biogen, Inc. from 2001 to 2010, Vice President-Therapeutics at Merrimack Pharmaceuticals, Inc. from 2010 to 2016, Chief Development Officer at Morphic Holding, Inc., and Chief Operating Officer at Dragonfly Therapeutics, Inc. Education includes a doctorate from Harvard University, a graduate degree from Massachusetts Institute of Technology conferred in 1998, undergraduate and graduate degrees from Moscow Institute of Physics & Technology with an undergraduate degree conferred in 1997, and an undergraduate degree from Ryazan State Radio Technical University conferred in 1992.
Alexey A. Lugovskoy active positions
| Companies | Position | Start |
|---|---|---|
RusBioVentures LLC
 RusBioVentures LLC Investment ManagersFinance RBV Capital invests in companies located across the globe primarily in Russia. The fund targets companies operating in the fields of biopharmaceuticals, biomedical technology, bioinformatics, healthcare IT, and medical device industries. It provides financing for seed, early and later stage capital requirements and also makes co investments. | Consultant / Advisor | 2012-12-31 |
Diagonal Therapeutics, Inc.
 Diagonal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops drugs for oncology, immunology and rare diseases | Chief Executive Officer | 2021-12-31 |
Former positions of Alexey A. Lugovskoy
| Companies | Position | End |
|---|---|---|
| MERRIMACK PHARMACEUTICALS | Corporate Officer/Principal | 2015-12-31 |
| BIOGEN INC. | Corporate Officer/Principal | 2010-05-31 |
Dragonfly Therapeutics, Inc.
 Dragonfly Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and produces drugs for autoimmune disease, oncology, fibrosis & neuro-inflammation | Chief Operating Officer | - |
| MORC HOLD | Corporate Officer/Principal | - |
Training of Alexey A. Lugovskoy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
83
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes drugs for the treatment of immunological & autoimmune diseases and cancer | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Moscow Institute of Physics & Technology
 Moscow Institute of Physics & Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ryazan State Radio Technical University
 Ryazan State Radio Technical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RusBioVentures LLC
RusBioVentures LLC Investment ManagersFinance RBV Capital invests in companies located across the globe primarily in Russia. The fund targets companies operating in the fields of biopharmaceuticals, biomedical technology, bioinformatics, healthcare IT, and medical device industries. It provides financing for seed, early and later stage capital requirements and also makes co investments. | Finance |
Morphic Holding, Inc.
 Morphic Holding, Inc. Pharmaceuticals: MajorHealth Technology Develops oral integrin drugs | Health Technology |
Dragonfly Therapeutics, Inc.
Dragonfly Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops and produces drugs for autoimmune disease, oncology, fibrosis & neuro-inflammation | Commercial Services |
Diagonal Therapeutics, Inc.
Diagonal Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops drugs for oncology, immunology and rare diseases | Health Technology |
- Stock Market
- Insiders
- Alexey A. Lugovskoy
